Search and Filter
Results per Page:
One shot to save lives: Can a single HPV vaccine dose do the trick in children living with HIV?
From the Duerr lab, Vaccine and Infectious Disease Division
What doesn’t kill you makes you stronger
From Dr. Richard Zager, Clinical Research Division
Research at any cost?
A look ‘behind the scenes’ at the money that makes Fred Hutch research move.
Misbehaving monocytes drive graft-versus-host disease
From the Hill Lab, Translational Science and Therapeutics Division
Now you see them, now you don’t: Gene editing protects stem cells from CAR T therapy
From the Kiem lab, Translational Science and Therapeutics Division
More than a fertility struggle? Infertility’s tie to ovarian cancer risk
From the Harris research group, Public Health Sciences Division
How a century-old policy still shapes cancer survival today
From the Chow research group, Public Health Sciences Division
Post-translational modification of an essential viral protein regulates early infection
From the Avgousti Lab, Human Biology Division
Fewer HPV vaccine doses provide long-term, protective immune memory
From the Galloway Lab, Human Biology Division
Ancient heritage discovered for a family of antiviral proteins
From the Emerman and Malik Labs, Basic Sciences and Human Biology Divisions
Snapping the histone CENP-A in place for high-fidelity cell division requires supervision
From the Biggins Lab, Basic Sciences Division
Resulta que los antivirales contra el VHS están (y no están) a flor de piel
Del Laboratorio Zhu, División de Vacunas y Enfermedades Infecciosas
Donor factors influence success of fecal microbiota transplant
From the Rashidi Group, Pathogen Associated Malignancies Program of the Cancer Consortium and Clinical Research Division
COVID watchdawgs: SARS-CoV-2 at UW in the pandemic’s early days
From the Chu and Weil Labs, UW Medicine, in collaboration with the Cancer Basic Biology Program of the Cancer Consortium and Fred Hutch Vaccine and Infectious Disease Division
Identificación de anticuerpos potentes y ampliamente neutralizantes contra los sarbecovirus, incluidos el SARS-CoV-1 y el SARS-CoV-2
Del Laboratorio Overbaugh, División de Biología Humana
Breaking down barriers to clinical trial participation for people living with HIV
From the Menon group, Vaccine and Infectious Disease Division
Transient transfection to make vaccines: cutting corners, or taking the express lane?
From The Kublin and Corey Labs, Vaccine and Infectious Disease Division
Turns out, HSV antivirals are (and aren’t) skin-deep
From The Zhu Lab, Vaccine and Infectious Disease Division
From data to decisions: Enhancing CAR T-cell therapy with predictive modeling
From the Gauthier Group, Clinical Research Division
Magic mushrooms, real results: Psilocybin’s role in healthcare worker healing
From the Gooley Group, Clinical Research Division